Andrew Huberman· PhD
I'm most excited about the idea of uh um you know Laboratories or companies figuring out which the compounds Within These uh cannabinoids they're called within these products are actually responsible for lowering the eye pressure and could we get like a more potent eye specific longacting drug that's basically derived from the concept of cannabis but works better and is more compatible with not bringing along all the other adverse elements that can come with cannabis use